Speakers: Michele Smith MS SCT(ASCP) & Diane Davis Davey, MD

ASCCP Screening Guidelines: https://www.asccp.org/screening-guidelines

ASCCP Mobile App: https://www.asccp.org/mobile-app

ACS Cervical Cancer Updates: https://www.cancer.org/latest-news/acs-updates-cervical-cancer-screening-guidelines-to-start-screening-at-age-25.html

HPV Primary Platforms:

Roche cobas HPV: https://diagnostics.roche.com/us/en/products/params/cobas-hpv.html

BD Onclarity HPV: https://www.bd.com/en-us/offerings/capabilities/cervical-cancer-screening/onclarity-hpv-assay

Co-Testing:

Hologic Cotesting: https://www.hologic.com/about/hologic-highlights/screening-cervical-cancer-pap-and-hpv-testing-combined

Hologic Aptima: https://www.hologic.com/hologic-products/diagnostic-solutions/aptimathinprep-cervical-health

Hologic Cervista: https://www.hologic.com/package-inserts/diagnostic-products/cervista-hpv-hr-assay

BD SurePath: https://www.bd.com/en-us/offerings/capabilities/cervical-cancer-screening/cervical-sample-collection/surepath-liquid-based-pap-test

Articles attached:

Primary HPV Screen Only? Experts warn of risks. Ann Paxon from Cap Today

Cytopathology in focus: Abnormal Cervical Screening Tests: a personal approach. Barb Crothers and Diane Davey from Cap Today

Moving forward the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories from JASC (2020) 9, 291-303.